Prescient Therapeutics (ASX:PTX) YoY Rev. per Sh. Growth

: 0.00% (As of Dec. 2022)

View and export this data going back to 1986. Start your Free Trial

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Prescient Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 was 0.00%.

Prescient Therapeutics's Revenue per Share for the six months ended in Dec. 2022 was A$0.00.

Prescient Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Prescient Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prescient Therapeutics Annual Data

Trend

Jun12

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

YoY Rev. per Sh. Growth

Prescient Therapeutics Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
YoY Rev. per Sh. Growth																-	-	-	-	-

Prescient Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Prescient Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2022 is calculated as:

	YoY Rev. per Sh. Growth (A: Jun. 2022 )
=	(Revenue per Share (A: Jun. 2022 )	-	Revenue per Share (A: Jun. 2021 ))	/	\| Revenue per Share (A: Jun. 2021 ) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

Prescient Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2022 )
=	(Revenue per Share (Q: Dec. 2022 )	-	Revenue per Share (Q: Dec. 2021 ))	/	\| Revenue per Share (Q: Dec. 2021 )) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

Prescient Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Prescient Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Prescient Therapeutics (ASX:PTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (ASX:PTX) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.ptxtherapeutics.com

Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

Prescient Therapeutics (ASX:PTX) Headlines

No Headlines